Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Arcutis Biotherapeutics Inc. logo

Arcutis Biotherapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

9.10
 
USD
  
-0.35
  
(-3.70%)
Optionable: Yes  Market Cap: 978 M  90-day average vol: 4,657,515

Previous close: 9.45  Open: 9.36  Bid: 9.1  Ask: 9.38
52 week range    
1.76   
   15.21
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Sunday 21st April 2024
39
MarketXLS Rank
40
Value
53
Technical
26
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ARQT Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Amortization of intangibles312000.0750000.0
Basic EPS from continuing operations-3.8-4.18-5.66-3.78
Basic EPS total-3.8-4.18-5.66-3.78
Basic weighted shares outstanding36 M49 M55 M69 M
Cost of sales754000.05 M
Depreciation122000.0454000.0622000.0771000.0
DepreciationAndAmortization122000.0454000.0622000.0771000.0
Diluted EPS total-3.8-4.18-5.66-3.78
Diluted normalized net income/share-4.18-5.66-3.78
Diluted weighted shares outstanding36 M49 M55 M69 M
GeneralAndAdministrativeExpense21 M61 M122 M185 M
Gross operating profit3 M55 M
Income before tax-136 M-206 M-311 M-259 M
Income taxes-9 M-13 M-12 M3 M
InterestExpenseNonOperating16 M30 M
MiscOtherSpecialCharges967000.0173000.06 M12 M
Net income from total operations-136 M-206 M-311 M-262 M
NetIncomeCommonStockholders-136 M-206 M-311 M-262 M
NetIncomeContinuousOperations-136 M-206 M-311 M-262 M
NetNonOperatingInterestIncomeExpense-16 M-30 M
Normalized income-205 M
Operating income-137 M-207 M-302 M-241 M
Operating income before depreciation (EBITDA)-135 M-202 M-297 M-234 M
OperatingExpense137 M207 M305 M296 M
Other income net-967000.0-173000.0-6 M-12 M
OtherGandA21 M61 M122 M185 M
OtherOperatingExpenses-14 M-19 M-3 M-2 M
PromotionAndAdvertising2 M11 M
Research & development expense115 M146 M182 M111 M
ResearchExpense115 M146 M182 M111 M
Revenue per share312000.0750000.0
Selling Gen & administrative expense21 M61 M122 M185 M
SellingAndMarketingExpense2 M11 M
Total Income available for interest expense (EBIT)-136 M-206 M-296 M-229 M
Total common shares outstanding50 M50 M61 M97 M
Total net income-136 M-206 M-311 M-262 M
Total ordinary shares97 M97 M97 M97 M
Total revenues4 M60 M
TotalExpenses137 M207 M305 M301 M
TotalRevenue4 M60 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University